Search PubMedSearch

SEARCH · Search PubMed

Results for “Life Expectancy”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

Estimated life expectancy of diabetics.

Life expectancy among diabetics in Iowa was estimated by using mortality data for the state. The Iowa general population had a higher life expectancy than the diabetic population at every age, except at ages 80 and over for men and ages 75 and over for women. The estimated life expectancy of 59.7 years at birth for diabetic males and of 69.8 years for diabetic females was lower than that for the Iowa general population by 9.1 years among males and 6.7 years among females. This difference narrowed with increasing age. The Iowa figures were similar to the estimates of life expectancy for the diabetic popullation of Pennsylvania.

Adult

Life expectancy of mentally retarded persons in Canadian institutions.

Data obtained from Statistics Canada were presented on the mortality level and expectancy of life for profoundly retarded and severely and moderately retarded persons in Canadian institutions for the years 1966 through 1968. Previous studies of mortality statistics were reported in mortality rates, average age at death, and crude death rates which are affected by the age distribution of the population involved. The very young and the very old are underrepresented in institutions, and thus these measures are not as accurate as life expectancy tables, which present the number of years expected to live, are independent of age distribution, and provide a reliable statistical measure for future replication and international comparisons. Retarded persons in institutions are living longer than previously, but their life expectancy does not meet that of the general population. Estimates of life expectancy for this population are vital for planning purposes.

Adolescent

Smoking and life expectancy among U.S. veterans.

Life expectancies were estimated for selected groups of smokers, ex-smokers, and nonsmokers based on the results of a 16-year mortality follow-up of 198,820 U.S. veterans. Life expectancy varied inversely with number of cigarettes smoked per day. The most pronounced differences were between nonsmokers and heavy cigarette smokers (40+ per day). These differences in life expectancy were greatest at the younger ages--nearly 9 years at ages 35 and 40. Life expectancies for cigarette smokers varied directly with age began smoking. For all ages, differences in life expectancy between nonsmokers and ex-cigarette smokers who stopped for other than doctor's orders were less than those between nonsmokers and current cigarette smokers. Results in the present study clearly confirmed Hammond's earlier findings.

Adult

The effect of a reduction in leading causes of death: potential gains in life expectancy.

The potential gains in total expectation of life and in the working life ages among the United States population are examined when the three leading causes of death are totally or partially eliminated. The impressive gains theoretically achieved by total elimination do not hold up under the more realistic assumption of partial elimination or reduction. The number of years gained by a new-born child, with a 30 per cent reduction in major cardiovascular diseases would be 1.98 years, for malignant neoplasms 0.71 years, and for motor vehicle accidents 0.21 years. Application of the same reduction to the working ages, 15 to 70 years, results in a gain of 0.43, 0.26, and 0.14 years, respectively for the three leading causes of death. Even with a scientific break-through in combating these causes of death, it appears that future gains in life expectancies for the working ages will not be spectacular. The implication of the results in relation to the current debate on the national health care policy is noted.

Accidents, Traffic

The relationship between life expectancy and socioeconomic status in Arkansas: 1970 and 1990.

Life Expectancy at Birth is estimated for county populations in Arkansas in 1970, 1980 and 1990. Counties are grouped into quintiles at each time point according to the percent of persons below the poverty level. Comparisons are made between mean life expectancy in the highest and lowest socioeconomic group at each point in time as well as between the same group at 1970 and 1990. It is hypothesized that the high socioeconomic populations will experience an increase in mean life expectancy over the low socioeconomic populations between 1970 and 1990. Statistical analysis supports the hypothesis. These findings conform to those from earlier research in Ohio and may reflect a continuing deterioration in the relative standard of living of lower income groups in the United States subsequent to 1970.

Adolescent

Predicting treatment costs and life expectancy for end-stage renal disease.

To estimate the cumulative 10-year direct medical costs and life expectancy associated with different methods of treatment for end-stage renal disease, we assessed predictively three treatment transition options. It is predicted that if 1000 patients shift from facility to home dialysis for each of 10 years, life expectancy of the cohort will not be reduced, but there will be a reduction of $241 million in total costs. The same number shifting from facility dialysis to cadaveric transplantation are predicted to have a $279 to $330 million reduction in total costs but a reduction of 7 to 17 per cent in life expectancy. Shifting from home dialysis to transplantation is predicted to reduce total costs by +103 to $142 million, and life expectancy by 10 to 20 per cent. As new program policies for treatment of end-stage renal disease are developed, their effect on both costs and life expectancy needs to be considered.

Cadaver

A technique for estimating life expectancy with crude vital rates.

This paper describes a method of estimating life expectancy at birth on the basis of crude vital rates. The method is derived from stable population theory and it furnishes good estimates insofar as the current crude vital rates of a population are close to its intrinsic rates. This condition is generally met in closed populations which have not experienced sharp movements in fertility. The method is useful for estimating life expectancy in developing nations with good sample registration systems but for which information on age is of poor quality. It is also useful for estimating the movement of life expectancy in certain European nations in the period prior to regular census taking. There are a number of nations and regions in Europe for which long series of birth and death rates are available but for which census age counts are widely spaced.

Birth Rate

Life expectancy following aortofemoral arterial grafting.

The existence of symptomatic aortoiliofemoral occlusive vascular disease would appear to result in approximately a 10 year decrease in life expectancy compared to that of the "normal" population. However, a significant proportion of the cumulative mortality rate appears to be due to both coronary artery disease and diabetes mellitus, as patients with peripheral vascular disease had a near "normal" life expectancy in the absence of either coronary artery disease or diabetes mellitus. Neither the presence nor the anatomical location of occlusive disease distal to the comon femoral bifurication by itself decreased life expectancy compared to those patients with aortoliofemoral disease but without similar distal occusive disease. Low operative mortality rate, excellent long-term patency, and potentially "normal" life expectancy all encourage an aggressive operative approach in patients with symptoms of peripheral vascular disease but without either diabetes mellitus or coronary artery disease. Revascularization in those patients with diabetes mellitus should be directed at limb salvage rather than at relief of minor symptoms of ischemia.

Adult

Life expectancy in an aboriginal Malaysian population.

A life table for an aboriginal Malaysian population, the Semelai, living in West Malaysia, was constructed using censuses from 1965, 1969, and 1974; and interview data from 1974. The life expectancy at birth for this population, 54.0 years, was compared to that of other Malaysian populations and selected Asian populations. This comparison indicated that the Semelai were at a disadvantage compared to the Malaysian populations, but in a favorable position when compared with the other Asian populations.

Actuarial Analysis

Formulation of goals for life expectancy at birth in Costa Rica (report of one experience).

Costa Rican authorities have finished a national adaptation of the goals of the Hemisphere's Ten-Year Health Plan for the Americas and have formulated a National Health Plan for 1974-1980. This work was coordinated by the Health Sector Planning Unit and was assisted by various multidisciplinary and multi-institutional working groups. The methodology set forth in this article was developed by a group responsible for formulating goals with regard to life expectancy--the last of five health-related subjects analyzed, and one regarded as dependent on the rest. In brief, this methodology was as follows: Birth rates, death rates, and life expectancy at birth in the other countries of the Region and in a developed country (Sweden) were compared with those prevailing now and in the past in Costa Rica. This served as a basis for projecting Costa Rica's future prospects if no changes were made, or if certain changes were made through implementation of new programs. This was followed by analysis of leading caused of death in the country--by age group and vulnerability of those dying, and by probably reductions in mortality that would result from achieving the goals established for other programs. On this basis, various alternative reductions in mortality for each age groups were considered. Using these alternative, abridged life tables were devised, and these in turn were used to draw up a table showing the life expectancy at birth that would result from realization of each alternative. This made it possible to derive life expectancy goals that were consistent with the goals for reducing mortality in each age group that were formulated during the sectoral planning process. It is hoped that this general procedure, illustrated here with data from the Costa Rican case, may prove useful to others engaged in health planning work.

Adolescent

Potential gains in life expectancies by partial elimination of leading causes of death in Texas.

Potential gains in life expectancies among Texas population by partial elimination of 3 major causes of death are examined on the basis of the available statistics from the population census and mortality statistics for 1970. Contrary to the popular anticipation of longer potential gains, the results are not particularly encouraging. The number of years of life that would be gained during the working ages by 50% elimination of major cardiovascular diseases is less than 1/2 of 1 year, about 1/4 of 1 year by 50% elimination of malignant neoplasms, and less than 1/4 of 1 year by 50% elimination of motor vehicle accidents. Even with a scientific breakthrough in combating those causes of death it appears that future gains in life expectancies for working ages will not be spectacular. The implications of the results in relation to the current debate on the national health policy are discussed.

Accidents, Traffic

Life expectancy, its relation to sexual activity and body weight in male inbred mice.

Body weight of male mice of five inbred strains caged in groups of five was determined three times between the ages of 80 and 100 days, representing the individual fully grown body weight. Sexual activity of each mouse (number of ejaculations and intromissions) was estimated under competitive conditions between the ages of 120 and 150 days in eleven repetitions. Within all inbred strains only about half of the males displayed sexual activity when confronted with an estric female. The other do not. The animals remained in their cage groups until natural death after 727 +/- 215 days (C57BL/6), 638 +/- 260 days (BALB/c), 630 +/- 187 days (CBA), 560 +/- 230 days (DBA/2) and 317 +/- 62 (AKR) days. Only amongst the sexually active animals did individual life span correlate with the number of ejaculations. This was seen in C57BL/6, CBA and DBA/2. Particularly sexually successful animals, carrying out the most ejaculations, live 10-20% longer than their (subdominant) competitors displaying less sexual success. Sexually inactive males (characterised by no ejaculations and less other sexual activities) show that this characteristic of their personalities imposes no limitation upon their life expectancy. Fully grown body weight and the individual life span correlates within the strains DBA/2, C57BL/6 and BALB/c. Medium-sized animals have a greater life expectancy than small or large ones.

Animals

The late effects of selected immunosuppressants on immunocompetence, disease incidence, and mean life-span. III. Disease incidence and life expectancy.

The effect of various immunosuppressive treatments on mean life-span and disease incidence have been studied. Significant life shortening was seen only in mice which recieved X-irradiation early in life and can be ascribed primarily to an increased incidence of certain malignancies. Marginal life shortening was seen in cyclophosphamide-treated animals, however, survival patterns between those and control animals did not differ until 30 months of age and the magnitude of life-shortening never approached that seen in X-irradiated animals. Thymectomy, splenectomy or cortisone treatment did not alter survival. All immunosuppressive treatments enhanced mortality due to non-neoplastic diseases, however, only a small percentage of animals die with these disease entities. With the exception of cortisone all immunosuppressive treatments increased the incidence of neoplastic disease. However, their effects on various neoplastic processes were variable and unpredictable. Four primary patterns in terms of relative immune competence, disease incidence and life expectancy were seen. Thus, immunodepression may of may not correlate with increased disease incidence, which in turn may or may not have a life-shortening effect. These findings are discussed in terms of the marked reduction of both humoral and cell-mediated immunity normally seen in aged mice and the significance of postulated immune surveillance mechanisms to survival.

Age Factors

Life expectancy without surgery in tetralogy of Fallot.

All published autopsy cases of patients with tetralogy of Fallot who died without surgical treatment were studied to determine the life expectancy of such persons. In addition, the data from a study of persons with tetralogy alive in Denmark in 1949 were reanalyzed. The survival data from these two sources were remarkably similar, indicating that 66 percent of persons with tetralogy of Fallot not treated surgically live to age 1 year, 49 percent to age 3 years and 24 percent to age 10 years; thereafter, the hazard function (or instantaneous risk of death) remains constant. The chance of survival is significantly less when pulmonary atresia, rather than stenosis, is present.

Adolescent

Follow-up 15 years after a geronto-psychiatric prevalence study. Conditions concerning death, cause of death, and life expectancy in relation to psychiatric diagnosis.

In relation to a follow-up 15 years after a geronto-psychiatric prevalence investigation of the population aged 65+ in a rural population, analysis has been made of the type of death certificate, residence at time of death, place of death, cause of death and life-expectancy in relation to psychiatric diagnoses prevalent in 1961.

Aged